newsfilter
← Latest News
GlobeNewswire·

IBN Initiates Coverage of Soligenix Inc.

AUSTIN, Texas, March 25, 2025 (GLOBE NEWSWIRE) -- via IBN – Soligenix Inc. (NASDAQ:SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases with an unmet